Full Press Release Details
Mdxhealth Announces Resignation of Board Member
IRVINE, CA, and HERSTAL, BELGIUM -
February 16, 2024 (GlobeNewswire) - MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage
precision diagnostics company, today announced that Jan Pensaert has stepped down from
the Board of Directors of mdxhealth. His resignation was effective as of February 15, 2024. Mr. Pensaert's resignation is not the result of any disagreement with the Company on any matter relating to the operations, policies
or practices of the Company.
Michael K. McGarrity, CEO of mdxhealth, commented:
"On behalf of the Board of Directors and the employees of mdxhealth, I would like to thank
Jan for his support of our Company. Jan provided valuable insights during a period of significant transformation for mdxhealth, and we
are grateful for his contributions."
Mdxhealth is a commercial-stage precision diagnostics
company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company's tests are based
on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis
facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
LifeSci Advisors (IR & PR)